Alcon AG | ALC - Current Liabilities


Alcon AG reported $3B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AstraZeneca USD 31.55B 1.02B Jun/2026
Bayer EUR 33.46B 875M Mar/2026
Essilor EUR 12.64B 490M Jun/2026
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
GRIFOLS EUR 2.24B 112M Jun/2026
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.75B 374M Jun/2026
Philips EUR 7.42B 8M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Smith & Nephew USD 2.05B 510M Jun/2026
Sonova Holding CHF 1.5B 303M Jun/2025
UCB EUR 4.4B 470M Dec/2025